News related to
across

Dubai Chamber of Commerce has launched the Bulgarian Business Council, marking a new institutional step aimed at expanding bilateral trade, strengthening commercial partnerships and encouraging mutual investment between Dubai and Bulgaria.

The council has been established under the umbrella of Dubai Chambers and is intended to serve as a structured platform for companies from both markets to collaborate, exchange market intelligence and identify joint opportunities. Officials involved in the initiative said the move reflects growing interest among Bulgarian firms in using Dubai as a regional base, while Dubai-based businesses increasingly view Bulgaria as a gateway to the European Union and South-Eastern Europe.

The new body brings together representatives from key sectors including manufacturing, logistics, food and agriculture, information technology, tourism, construction and renewable energy. Its mandate includes organising business delegations, facilitating B2B meetings, supporting regulatory understanding and helping members navigate investment frameworks in both jurisdictions. Dubai Chamber of Commerce indicated that the council will also work closely with public institutions and trade promotion agencies in Bulgaria to ensure alignment with national economic priorities.

Speaking at the launch, Dubai Chambers officials said the council was designed to “build stronger partnerships between business communities and unlock new opportunities for joint investment”, highlighting a shared interest in diversifying trade flows and deepening private-sector engagement. Bulgarian representatives echoed that view, noting that Dubai’s position as a global trade and logistics hub offers Bulgarian exporters and investors access to markets across the Middle East, Africa and Asia.

Trade ties between Dubai and Bulgaria have been expanding steadily, supported by improved logistics links and a broader push by Dubai to strengthen economic relations with European economies. Non-oil trade between the UAE and Bulgaria has grown over the past decade, driven by machinery, metals, chemicals, food products and pharmaceuticals, according to publicly available trade data. Dubai’s role as a re-export centre has also helped Bulgarian firms reach third markets more efficiently.

The launch of the Bulgarian Business Council fits into Dubai Chamber of Commerce’s wider strategy of establishing country-specific business councils to institutionalise trade relations and provide structured support to foreign investors. Dubai Chambers now hosts dozens of such councils, covering markets across Europe, Asia, Africa and the Americas. These councils have become a central tool in Dubai’s efforts to attract foreign direct investment, promote cross-border partnerships and reinforce the emirate’s status as a preferred base for international companies.

Analysts note that Bulgaria’s competitive advantages include its EU membership, relatively low operating costs, skilled workforce and strategic location linking Europe, the Balkans and the Black Sea region. For Dubai-based companies, these factors make Bulgaria an attractive destination for manufacturing, near-shoring, logistics and technology development. At the same time, Bulgarian companies see Dubai as a stable business environment with advanced infrastructure, business-friendly regulations and strong connectivity.

Investment interest between the two sides has been widening beyond traditional trade. Sectors such as renewable energy, agri-tech, fintech, health care and tourism development have emerged as areas of mutual focus. Bulgarian technology firms have shown growing interest in Dubai’s innovation ecosystem, while companies from Dubai are exploring opportunities in Bulgaria’s industrial zones, real estate and tourism assets.

The Bulgarian Business Council is expected to play a coordinating role in these areas by aligning private-sector initiatives with broader economic strategies. Its agenda includes promoting joint ventures, supporting start-ups seeking cross-border expansion and encouraging knowledge exchange in areas such as digitalisation and sustainability. Council members will also work to address practical barriers faced by businesses, including regulatory clarity, market entry requirements and partner identification.

Diplomatic and business officials involved in the initiative stressed that the council is intended to complement, rather than replace, existing government-to-government frameworks. By focusing on commercial engagement, it aims to translate high-level economic cooperation into tangible outcomes for companies operating on the ground. Similar councils under Dubai Chambers have previously been credited with accelerating deal-making and improving investor confidence by providing direct access to market insights and decision-makers.

Danish pharmaceutical company Novo Nordisk has launched its blockbuster diabetes and weight-related therapy Ozempic in India, making the semaglutide-based injectable available across the country with a starting cost of about ₹2,200 per week for the lowest 0.25 mg dose. The move positions Ozempic as a key element in the fast-evolving metabolic health market, where type 2 diabetes and obesity rates are among the highest globally.

Available in pre-filled pens with 0.25 mg, 0.5 mg and 1 mg strengths, the therapy has been approved in India as an adjunct to diet and exercise for adults with uncontrolled type 2 diabetes. Novo Nordisk has set the monthly cost for the 0.25 mg dose at approximately ₹8,800, with incremental pricing for the higher strengths. The company says Ozempic delivers benefits beyond glycaemic control, including cardiovascular and kidney risk reduction, and supports weight management through appetite suppression.

India’s diabetes burden is among the world’s largest, with more than 100 million adults affected, according to World Health Organization estimates. Additionally, hundreds of millions live with overweight or obesity, factors that increase the risk of metabolic complications. The introduction of a globally validated therapy such as Ozempic provides clinicians with another option in managing these interconnected health challenges.

Industry analysts note that the launch comes as the country becomes a major battleground for GLP-1 receptor agonist drugs — a class that includes semaglutide and competitors such as Eli Lilly’s tirzepatide, marketed locally as Mounjaro. These therapies mimic gut hormones to regulate blood glucose and appetite, and have become focal points in efforts to curb both diabetes and excess weight.

Novo Nordisk’s roll-out follows the entry of Wegovy, its higher-dose semaglutide formulation specifically approved for chronic weight management, which debuted in India earlier in the year. Wegovy’s pricing adjustments have sparked a noticeable uptick in uptake, highlighting how cost influences adoption of these premium therapies. Ozempic’s pricing at a relatively lower weekly rate aims to broaden its accessibility, though some clinicians stress that affordability will remain a concern for patients without comprehensive insurance coverage.

The timing of the launch intersects with ongoing intellectual property developments. While the core semaglutide patent has expired in India, a secondary patent covering specific formulations remains valid until early 2026, limiting domestic generic competition. Indian courts have recently allowed local firms such as Sun Pharmaceutical Industries and Dr. Reddy’s Laboratories to manufacture semaglutide for export to countries where Novo Nordisk holds no patent but have barred domestic sales of these versions until the formulation patent lapses, shaping competitive dynamics in the near term.

Novo Nordisk India’s managing director, Vikrant Shrotriya, has acknowledged that the weekly pricing is positioned to balance accessibility with the company’s investment in supply infrastructure. He said the goal is to expand reach beyond major urban centres to tier-1 and tier-2 cities and dedicated diabetes clinics, where consistent access to modern therapies has traditionally lagged. Clinicians emphasise that appropriate patient education and specialist referrals will be crucial in ensuring safe and effective use, given that semaglutide therapies require monitoring for gastrointestinal and metabolic effects as part of comprehensive care.

The launch also intersects with broader digital health initiatives. Local health-tech firms are partnering with international drugmakers to offer patient support programmes that provide coaching and adherence tools for individuals on GLP-1 therapies. These services aim to bolster outcomes by integrating medication with lifestyle guidance, reflecting a holistic approach to long-term metabolic health management.

Abu Dhabi has hosted the CGIAR System Council meeting for the first time in the Arabian Gulf region, marking a significant moment for global agricultural governance and underscoring the UAE’s ambition to position itself as a convening hub for food systems innovation, climate resilience and sustainable development.

The gathering brought together representatives of governments, multilateral organisations, donors and research leaders who collectively oversee CGIAR, the world’s largest public agricultural research partnership. The System Council sets strategic direction, approves funding allocations and assesses the impact of research programmes that influence food security for hundreds of millions of people, particularly in climate-vulnerable regions.

Hosting the council in the UAE reflects a broader shift in global agricultural research towards regions facing acute water stress, rising temperatures and land degradation. Officials involved in the meeting emphasised that solutions for future food systems must be designed and tested in environments that mirror the challenges many countries already face, including arid climates and fragile ecosystems. The Gulf, long associated with food import dependence, is increasingly presented as a laboratory for innovation in desert agriculture, controlled-environment farming and climate-smart technologies.

CGIAR’s research portfolio spans crop improvement, climate adaptation, nutrition, water management and biodiversity conservation. Its network includes 15 research centres operating across Africa, Asia, Latin America and parts of the Middle East. Discussions in Abu Dhabi focused on aligning research priorities with accelerating climate risks, tightening development budgets and the need to demonstrate measurable outcomes for smallholder farmers and vulnerable communities.

Senior figures attending the meeting highlighted the urgency of scaling innovations that improve productivity while reducing environmental footprints. Heat-tolerant crop varieties, drought-resilient seeds, precision irrigation systems and data-driven advisory services were cited as areas where scientific advances are already delivering tangible benefits. Council members also reviewed progress on integrating gender equity and nutrition outcomes into agricultural research, recognising that yield gains alone do not guarantee food security.

The UAE’s role as host was framed around its investments in agri-tech, food security strategies and international development partnerships. Over the past decade, the country has expanded funding for agricultural research, supported pilot projects in arid farming and strengthened ties with international institutions working on climate adaptation. Officials involved in organising the meeting said the decision to host the council aligned with national priorities on sustainable food production and knowledge-based economic diversification.

Beyond symbolism, the location influenced the agenda. Sessions examined how lessons from desert agriculture can be adapted for other water-scarce regions, including parts of Africa and Central Asia. Controlled-environment agriculture, including greenhouse and vertical farming, featured prominently as participants assessed their potential to complement open-field farming rather than replace it. Energy use, affordability and scalability in lower-income settings were central to these debates.

Financing emerged as a critical issue. CGIAR operates in an environment of competing global crises, where humanitarian needs, climate finance and development assistance all draw from limited public funds. Council members discussed strategies to broaden the donor base, attract blended finance and strengthen partnerships with the private sector without compromising CGIAR’s public-good mandate. Transparency, accountability and rigorous impact evaluation were repeatedly emphasised as essential to maintaining donor confidence.

The meeting also addressed governance reforms within CGIAR, which has undergone structural changes aimed at improving coordination across its research centres. Council members reviewed progress on streamlining programmes, reducing duplication and enhancing collaboration with national research systems. Strengthening ties with regional institutions in the Middle East and North Africa was identified as an opportunity to expand the reach of research outputs while respecting local contexts.